Home › Funds › KVP Capital Advisors, LP › CMPX
KVP Capital Advisors, LP position in CMPX
COMPASS THERAPEUTICS INC · Health Care
KVP Capital Advisors, LP reported holding 771,000 shares of CMPX (COMPASS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.7M, representing 1.24% of its reported portfolio and ranking #30 among its reported holdings. KVP Capital Advisors, LP has disclosed CMPX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How KVP Capital Advisors, LP's CMPX position evolved
KVP Capital Advisors, LP first disclosed a stake in CMPX in Q1 2026 at 500,000 shares (US$2.6M). Across 2 filings, KVP Capital Advisors, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 771,000 shares valued at US$1.7M — an increase of 271,000 shares quarter over quarter.. Notable position changes include a 54% increase in Q2 2026 (shares fell 53% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 500.00K | $2.65M | New |
| Q2 2026 | 771.00K | $1.69M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CMPX and 13F data
CMPX (COMPASS THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in CMPX — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$39.4M), ORBIMED ADVISORS LLC (US$33.3M), MONTANOVA CAPITAL, LLC (US$30.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CMPX
- TANG CAPITAL MANAGEMENT LLC 17.99M sh · $39.40M · Q2 2026
- ORBIMED ADVISORS LLC 15.22M sh · $33.33M · Q2 2026
- MONTANOVA CAPITAL, LLC 14.10M sh · $30.88M · Q2 2026
- Enavate Sciences GP, LLC 7.79M sh · $17.06M · Q2 2026
- Vivo Capital, LLC 7.76M sh · $16.99M · Q2 2026
- Palo Alto Investors LP 5.83M sh · $12.77M · Q2 2026
- Birchview Capital, LP 1.68M sh · $3.67M · Q2 2026
- Atle Fund Management AB 1.05M sh · $2.30M · Q2 2026
More on KVP Capital Advisors, LP
FAQ
How long has KVP Capital Advisors, LP held CMPX?
KVP Capital Advisors, LP has disclosed CMPX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is KVP Capital Advisors, LP's current position in CMPX?
As of Q2 2026, KVP Capital Advisors, LP holds 771.00K shares of CMPX (COMPASS THERAPEUTICS INC), valued at $1.69M, representing 1.24% of its reported portfolio and ranking #30.
Has KVP Capital Advisors, LP been buying or selling CMPX?
In the latest 13F filing (Q2 2026), KVP Capital Advisors, LP increased its position in CMPX.
Which other funds hold CMPX?
Other major institutional holders of CMPX include TANG CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, MONTANOVA CAPITAL, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.